{"id":53591,"date":"2023-02-02T21:02:10","date_gmt":"2023-02-02T20:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/"},"modified":"2023-02-02T21:02:10","modified_gmt":"2023-02-02T20:02:10","slug":"exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/","title":{"rendered":"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team"},"content":{"rendered":"
\n

PALO ALTO, Calif.–(BUSINESS WIRE)–Exai Bio announced today that it has added two new members to its executive leadership team \u2014 Emi Zychlinsky as Executive Vice President, Operations, and Seema Singh Bhan as Senior Advisor, Public Policy and External Affairs \u2014 to strengthen the company\u2019s operational infrastructure and foster meaningful engagement with policymakers, regulators and advocacy organizations.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cEmi and Seema are deeply experienced and passionate industry leaders, and everyone on the Exai team is thrilled to welcome them to our team,\u201d said Patrick Arensdorf, Chief Executive Officer of Exai. \u201cEmi will help build processes and systems to help Exai grow quickly, deliberately and responsibly; Seema will lead our engagement with policymakers, regulators and advocacy organizations as we navigate this very dynamic healthcare space.\u201d\n<\/p>\n

\nZychlinsky has more than 25 years of experience in the development of diagnostic tests from product concept to commercialization. She has a proven track record of building operational infrastructure and designing and implementing worldwide quality systems and regulatory strategies. Most recently, Zychlinsky served as Senior Vice President of Quality Assurance and Regulatory Affairs for the global team at Standard BioTools (formerly Fluidigm). Previous to this, she was Chief Technology Officer at Diadexus.\n<\/p>\n

\nSingh Bhan brings more than two decades of experience in government affairs, public policy, and advocacy. She has a successful track record of bringing together diverse stakeholders, including policy makers, regulators, industry and advocacy groups, and academic leaders, to work on advancing breakthroughs in science and technology. Prior to joining Exai, Singh Bhan was Senior Vice President, Public Policy and External Affairs, at Thrive Early Detection Corp. Previously, she was Vice President, Head of Public Policy at Foundation Medicine, where she was instrumental in the success of the landmark parallel review decision by the FDA and CMS on next-generation sequencing for Foundation Medicine\u2019s flagship product, FoundationOne CDx. Singh Bhan also spent well over a decade in public service, serving as Senior Counsel to the Senate Judiciary Committee and working with Senator Arlen Specter.\n<\/p>\n

\nAbout Exai Bio<\/b>\n<\/p>\n

\nExai Bio<\/a> is a next-generation liquid biopsy company. Its mission is to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized and targeted way, and ultimately cured. The company\u2019s proprietary RNA and artificial intelligence-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nBrad Hennig
\n
brad@hennigcommunications.com<\/a>
(415) 307-7856\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PALO ALTO, Calif.–(BUSINESS WIRE)–Exai Bio announced today that it has added two new members to its executive leadership team \u2014 Emi Zychlinsky as Executive Vice President, Operations, and Seema Singh Bhan as Senior Advisor, Public Policy and External Affairs \u2014 to strengthen the company\u2019s operational infrastructure and foster meaningful engagement with policymakers, regulators and advocacy … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53591","6":"format-standard","7":"category-industry"},"yoast_head":"\nExai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif.–(BUSINESS WIRE)–Exai Bio announced today that it has added two new members to its executive leadership team \u2014 Emi Zychlinsky as Executive Vice President, Operations, and Seema Singh Bhan as Senior Advisor, Public Policy and External Affairs \u2014 to strengthen the company\u2019s operational infrastructure and foster meaningful engagement with policymakers, regulators and advocacy ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-02T20:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230202005804\/en\/1704306\/21\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team\",\"datePublished\":\"2023-02-02T20:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005804\\\/en\\\/1704306\\\/21\\\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/\",\"name\":\"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005804\\\/en\\\/1704306\\\/21\\\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg\",\"datePublished\":\"2023-02-02T20:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005804\\\/en\\\/1704306\\\/21\\\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230202005804\\\/en\\\/1704306\\\/21\\\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/","og_locale":"en_US","og_type":"article","og_title":"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Pharma Trend","og_description":"PALO ALTO, Calif.–(BUSINESS WIRE)–Exai Bio announced today that it has added two new members to its executive leadership team \u2014 Emi Zychlinsky as Executive Vice President, Operations, and Seema Singh Bhan as Senior Advisor, Public Policy and External Affairs \u2014 to strengthen the company\u2019s operational infrastructure and foster meaningful engagement with policymakers, regulators and advocacy ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-02T20:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230202005804\/en\/1704306\/21\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team","datePublished":"2023-02-02T20:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/"},"wordCount":414,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005804\/en\/1704306\/21\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/","url":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/","name":"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230202005804\/en\/1704306\/21\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg","datePublished":"2023-02-02T20:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230202005804\/en\/1704306\/21\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230202005804\/en\/1704306\/21\/Exai-BizWire-Card-Emi-Seema-2400x1350-Feb23.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53591"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53591\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}